BeiGene (BGNE) Misses Q3 EPS by 26c

BeiGene (NASDAQ: BGNE) reported Q3 EPS of ($1.08), $0.26 worse than the analyst estimate of ($0.82).

Cash, Cash Equivalents, and Short-term Investments were $203.62 million as of September 30, 2016, compared to $100.49 million as of December 31, 2015. The increase reflects net initial public offering (IPO) proceeds received in the first quarter of 2016, partially offset by cash used in operating activities for the nine months ended September 30, 2016.

For earnings history and earnings-related data on BeiGene (BGNE) click here.

You May Also Be Interested In

• Sinda raises $331M in IPO, reports Q2 net loss of $16.6M
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79